ALFA Finder| Management target | Revenue FY27 |
|---|
| Revenue growth | 36% YoY Consolidated |
|---|---|
| Margins | Consolidated EBITDA margins stable at 26% |
| Order book | Recent LOIs/Contracts total ₹17,496 Crores |
| Demand visibility | Strong, backed by long-term LOIs and contracts |
| Management confidence | High, citing strong product pipeline and sustained momentum |
Growth
Consolidated Revenue grew 36% YoY to ₹6,675 Mn; EBITDA grew 35% to ₹1,749 Mn; PAT grew 6% to ₹512 Mn.
Outlook
Strong order book of ₹17,496 Cr. Commercializing ETFA via flow chemistry and expanding into battery chemicals by FY27.
Risks
Finance costs rose significantly YoY. Risks include international growth management and currency fluctuations.
Last quarter's promises, checked
Delivered
- Guided working capital improvement → delivered OCF of ₹334 Cr (= BEAT)
- Targeted 24%-odd EBITDA margin → delivered 26% (= BEAT)
- Guided 60-70% annual revenue growth for FY26 → delivered 65% (= BEAT)
Partly delivered
- Guided 25% tax rate → delivered Q1FY27 PAT growth of only 6% despite 36% revenue growth (= PARTIAL)
Investor Presentation filed with BSE, NSE: ANURAS. Summary written with AI assistance from the document.
Anupam Rasayan India Ltd: key numbers
- Share price
- ₹1,196.20
- Market cap
- ₹13,619 Cr
- Revenue (annual)
- ₹2,365 Cr
- Net profit (annual)
- ₹170.1 Cr
- P/E (TTM)
- 75.5×Sector 35.5×
- Promoter holding
- 59.07%+0.00% QoQ
- FII holding
- 8.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anupam Rasayan India Ltd
All →Anupam Rasayan India Earnings Call Transcript: Key Takeaways
Q2 income up 11% to ₹821 Cr; EBITDA up 41% to ₹202 Cr at 25% margin. Bliss GVS closed 28 Sep, so only three days are consolidated. Management avoided quantifying Bliss and M&A.
Anupam Rasayan India Investor Presentation: Key Takeaways
Q2FY27 consolidated total income ₹821 Cr (+11% YoY), EBITDA ₹202 Cr (+41%, 25% margin), PAT ₹65 Cr (+14%). Controlling stake in Bliss GVS Pharma acquired 28 Sep 2026.
Anupam Rasayan India Q2 FY27 Results: Net Profit ₹65 Cr, Up 13.6% YoY
Anupam Rasayan India Ltd reported revenue from operations of ₹805.9 Cr (+10.2% YoY) and net profit of ₹65 Cr (+13.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65 Cr · +13.6% YoY
Anupam Rasayan India Board Meeting Date
Anupam Rasayan India scheduled a November 6, 2026 board meeting to approve unaudited standalone and consolidated results. The trading window stays closed until November 8.
Anupam Rasayan India Annual General Meeting
Anupam Rasayan India Limited filed copy of minutes of its Annual General Meeting held on September 30, 2026. The filing is procedural and carries no financial or business event.
Anupam Rasayan India Other Announcement
Anupam Rasayan India disclosed a Crisil ESG rating of 62 and Core ESG rating of 63 (Strong). No transaction or business decision is involved.